Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02607085 · ClinicalTrials.gov registry record

REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study

A clinical trial, sponsored by ZS Pharma.

Completed
Registry status
203
Enrollment target

NCT02607085 is a clinical trial that has completed, run by ZS Pharma. The registered enrollment target is 203 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02607085 has completed, sponsored by ZS Pharma.

COMPLETED
Registry status
203 participants
Enrollment target

Study Summary

This study evaluates the management of subjects with Standard of Care (SOC) when admitted to the Emergency Department (ED) with hyperkalemia (potassium value ≥ 5.5 mmol/L). Demographics and medical history data, including previous ED visits and/or hospital admissions for hyperkalemia and reason for current ED admission, will be recorded. Subjects who receive an intervention/treatment for hyperkalemia will have study-related potassium values determined at 30 minutes, 1, 2, and 4 hours after the start of treatment. Subjects who receive no intervention/treatment during the initial 4-hour period will have a study-related potassium value determined 4 hours after the baseline potassium measurement. Available data obtained as part of SOC management will include physical examinations, vital signs, fluid intake and urine output, ECGs, clinical laboratory data, and results of chest x-rays. Data regarding the subject's chief complaint upon admission to the ED, the possible cause of the subject's hyperkalemia, and admitting and discharge diagnosis will be recorded; the subject's overall discharge summary will also be collected.

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2015-10-31
Est. Completion 2016-05-31

Sponsor

ZS Pharma

8 total trials

What the Registry Record Tells You About NCT02607085

The ClinicalTrials.gov registry entry for NCT02607085 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZS Pharma, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02607085 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02607085 about?

NCT02607085 is a clinical study titled "REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study". This study evaluates the management of subjects with Standard of Care (SOC) when admitted to the Emergency Department (ED) with hyperkalemia (potassium value ≥ 5.5 mmol/L). Demographics and medical history data, including previous ED visits and/or hospital admissions for hyperkalemia and reason for ...

What is the current status of trial NCT02607085?

This trial is currently completed. The enrollment target is 203 participants. The study started on 2015-10-31. Estimated completion is 2016-05-31.

Who is sponsoring clinical trial NCT02607085?

This trial is sponsored by ZS Pharma, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.